finance.yahoo.com
Every finance.yahoo.com story we have translated and published, newest first. · 13,390 stories
Finance
Tesla Maintained Its Majority of the U.S. EV Market in Q2, but That's Not All You Need to Know
Finance
Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year
Finance
Liquor industry struggles grow with another Chapter 7 filing
Finance
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Finance
The Metals Company Is Riding the Critical Metals Boom. Here's Why I Still Wouldn't Touch It.
Finance
One Social Security Move Boomers Used to Boost Their Checks Is Now Off-Limits to Almost Everyone Else.
Finance
Pemex and Petrobras Bet Big on High-Risk High-Reward Drilling Off Mexico
Finance
Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?
Finance
SK Hynix Is Buying Back 3.3% of Its Shares and Canceling Every One
Finance
CHAT vs. FTEC: Is Concentrated AI Exposure or Broad Tech Diversification the Better Play Right Now?
Finance
The Custodial Account You Opened for Your Grandson Becomes Legally His the Day He Turns 21, and He Can Spend It on a Car. A 529 Never Does.
Finance
This Company Just Paid Out $6.8 Billion. Its AI Bill Was 4x That
Finance
If a Bear Market Is Coming, Here's What All of the Smartest Investors Are Doing Right Now
Finance
Jim Cramer Says Stocks and the Economy Are Telling Two Very Different Stories: ‘Jarring Gulf’
Finance
UBS revamps S&P 500 target for rest of 2026
Finance
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?
Finance
Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?
Finance
$22 Billion in Customer Deposits Did Not Stop This Chip CEO From Selling $37 Million
Finance
Billionaire Druckenmiller makes cancer stock his #1 buy for a reason
Finance
After Buying Circle Through a 42% Drop, Cathie Wood Says Analysts Cannot Fathom It
Finance
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?
Finance
Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?
Finance
Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?
Finance
Your mortgage rate has a growing problem in the bond market
Page 275 / 558